Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:21 AM
Ignite Modification Date:
2025-12-25 @ 1:21 AM
NCT ID:
NCT00328393
Eligibility Criteria:
Inclusion Criteria:
* Age 45-75 years
* Diabetes mellitus Type 2 (HbA1c 7 - 8.5%)
* Casual blood pressure \> = 130/80 mmHg, \< 160/100 mmHg
Exclusion Criteria:
* Therapy with insulin
* Combination therapy of sulfonyl-urea und metformin
* Therapy with nateglinid, repaglinid or an other substance of this drug family
* Allergy against pioglitazone or other composites of the tablet
* History of heart failure (NYHA I bis IV)
* Hepatic insufficiency
* Transaminases \> 2.5-fold of the upper normal limit
* End-stage renal failure
* Syndrome of polycystic ovaries
* Absence of effective contraception in women of childbearing potential
* Pregnancy or breast-feeding
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT00328393
Study Brief:
Protocol Section:
NCT00328393